Abstract
Rebound insomnia has been reported upon discontinuation of benzodiazepines. We describe the first case of a sleep polygraphically documented rebound insomnia with an unusual somatic fatigue syndrome after long-term use of clozapine in a 30-year-old schizophrenic male. The withdrawal symptoms occurred the first day after drug discontinuation and could be stopped by readministering clozapine. In our opinion, the sudden occurrence of the withdrawal symptoms cannot be explained by a dopaminergic hypersensitivityor a cholinergic rebound, but indicates an involvement of GABAergic and perhaps antiglutamatergic properties of clozapine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alphs LD, Lee HS (1991) Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study. J Clin Psychiatry 52:346
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R), 3rd edn, revised. American Psychiatric Press; Washington, DC
Anderman B, Griffith RW (1977) Clozapine-induced agranulocytosis: a situation report up to 1976. Eur J Clin Pharmacol 11: 199–201
Baron JC, Martinot JL, Cambon H, Boulenger JP, Poirier MF, Caillard V, Blin J, Huret JD, Loc'h C, Maziere B (1989) Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels. Psychopharmacology 99:463–472
Borison RL, Diamond BI, Sinha D, Gupta RP, Ajiboye PA (1988) Clozapine withdrawal rebound psychosis. Psychopharmacol Bull 24:260–263
Cambon H, Baron JC, Boulenger JP, Loc'h C, Zarifian E, Maziere B (1987) In vivo assay for neuroleptic receptor binding in the striatum: positron emission tomography in humans. Br J Psychiatry 151:824–830
Chouinard G, Jones BD (1980) Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics. Am J Psychiatry 137:16–21
Dickson R, Williams R, Dalby JT (1994) Dystonic reaction and relapse with clozapine discontinuation and risperidone initiaton. Can J Psychiatry 39(3):184
Drew KL, O'Connor WT, Kehr J, Ungerstedt U (1990) Regional specificity of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. Eur J Pharmacol 187:385–397
Ekblom B, Eriksson K, Lindstrom LH (1984) Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology 83:293–294
Eklund K (1987) Supersensitivity and clozapine withdrawal. Psychopharmacology 90:135
Gillin JC, Spinweber CL, Johnson LC (1989) Rebound insomnia: a critical review. J Clin Psychopharmacol 9(3):161–172
Graham SR, Kokkinidis L (1993) Clozapine inhibits limbic system kindling: implications for antipsychotic action. Brain Res Bull 30:597–605
Klimke A, Klieser E (1995) The atypical neuroleptic clozapine (Leponex): state of the art and recent clinical aspects. Fortschr Neurol Psychiatrie 63:173–193
Krupp P, Barnes P (1992) Clozapine-associated agranulocytosis: risk and aetiology. Br J Psychiatry 160 (Suppl 17):38–40
Lidsky TI, Alter E, Banerjee SP (1991) Effects of clozapine on glutamatergic transmission. Soc Neurosci 17:686
Lieberman JA, Alvir JM (1992) A report of clozapine-induced agranulocytosis in the United States. Drug Safety 7 (Suppl 1): 1–2
Luchins DJ, Freed WJ, Wyatt RJ (1980) The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs. Am J Psychiatry 137(11): 1395–1398
Meltzer HY, Bastani B, Ramirez LF, Matsubara S (1989) Clozapine: new research on efficacy and mechanism of action. Eur Arch Psychiatry Clin Neurosci 238:332–339
Parsa MA, al-Lahham YH, Ramirez LF, Meltzer HY (1993) Prolonged psychotic relapse after abrupt clozapine withdrawal. J Clin Psychopharmacol 13(2):154–155
Perenyi A, Kuncz E, Bagdy G (1986) Early relapse after sudden withdrawal or dose reduction of clozapine. Psychopharmacology 86:244
Rechtschaffen A, Kales A (1968) A manual of standarized terminology, techniques and scoring system for sleep stages of human subjects. Public Health Service, Washington DC, NIH, Pub No 204. US Government Printing Office
Simpson GM, Lee JH, Shrivastava RK (1978) Clozapine in tardive dyskinesia. Psychopharmacology 56:75–80
Staedt J, Stoppe G, Kögler A, Riemann H, Hajak G, Munz DL, Emrich D, Rüther E (1995) Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2 receptor alteration. Eur Arch Psychiatry Clin Neurosci 245: 8–10
Ungerstedt R, Ljungberg T (1977) Behavioral, patterns related to dopamine neurotransmission: effects of acute and chronic antipsychotic drugs. In: Costa E, Gessa GL (eds) Advances in biochemical psychopharmacology, vol 16. Raven Press, New York, pp 193–199
Zapletalek M, Preiningerova O, Hanus H (1980) Does clozapine cause dependence? Agressologie 21(A):19–22
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Staedt, J., Stoppe, G., Hajak, G. et al. Rebound insomnia after abrupt clozapine withdrawal. Eur Arch Psychiatry Clin Nuerosci 246, 79–82 (1996). https://doi.org/10.1007/BF02274897
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02274897